These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21659546)

  • 1. Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation.
    Chou YC; Lin SJ; Lu J; Yeh TH; Chen CL; Weng PL; Lin JH; Yao M; Tsai CH
    Blood; 2011 Aug; 118(5):1340-9. PubMed ID: 21659546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.
    Chou YC; Chen CL; Yeh TH; Lin SJ; Chen MR; Doong SL; Lu J; Tsai CH
    Am J Pathol; 2012 Nov; 181(5):1773-81. PubMed ID: 22974584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
    Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
    PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
    Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
    J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival.
    Huang YC; Lin SJ; Lin KM; Chou YC; Lin CW; Yu SC; Chen CL; Shen TL; Chen CK; Lu J; Chen MR; Tsai CH
    Blood; 2016 Sep; 128(12):1578-89. PubMed ID: 27338098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus.
    Kutz H; Reisbach G; Schultheiss U; Kieser A
    Virology; 2008 Feb; 371(2):246-56. PubMed ID: 17967471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
    Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
    Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
    Kilger E; Kieser A; Baumann M; Hammerschmidt W
    EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
    Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
    J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
    Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines.
    Tsai SC; Lin SJ; Chen PW; Luo WY; Yeh TH; Wang HW; Chen CJ; Tsai CH
    Blood; 2009 Jul; 114(1):109-18. PubMed ID: 19417211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Latent Membrane Protein 1 (LMP1).
    Kieser A; Sterz KR
    Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines.
    Higuchi M; Kieff E; Izumi KM
    J Virol; 2002 Jan; 76(1):455-9. PubMed ID: 11739714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1.
    Mosialos G; Hanissian SH; Jawahar S; Vara L; Kieff E; Chatila TA
    J Virol; 1994 Mar; 68(3):1697-705. PubMed ID: 8107230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
    J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
    Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
    J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.